Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study-Reference-Cited by-同舟云学术

Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study

Published:2022-11 Issue:11 Volume:21 Page:994-1003
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Schott Andersen Anne Sofie,Maarbjerg Stine,Noory Navid,Heinskou Tone Bruvik,Forman Julie Lyng,Cruccu Giorgio,Ashina Messoud,Bendtsen Lars

Funder

Novartis Pharma AG

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference37 articles.

1. The International Classification of Headache Disorders, 3rd edition;Cephalalgia,2018

2. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study;Mueller;Cephalalgia,2011

3. Trigeminal neuralgia--a prospective systematic study of clinical characteristics in 158 patients;Maarbjerg;Headache,2014

4. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia;Bendtsen;Lancet Neurol,2020

5. European Academy of Neurology guideline on trigeminal neuralgia;Bendtsen;Eur J Neurol,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OTULIN's influence on neuroinflammation and pain modulation in trigeminal neuralgia;CNS Neuroscience & Therapeutics;2024-08

2. Interdisciplinary strategies for diagnosis and treatment of trigeminal neuralgia;Swiss Medical Weekly;2024-07-24

3. Role of common and rare genetic variants in the aetiology of trigeminal neuralgia;2024-07-16

4. An update on pharmacotherapy for trigeminal neuralgia;Expert Review of Neurotherapeutics;2024-06-13

5. Pathology of pain and its implications for therapeutic interventions;Signal Transduction and Targeted Therapy;2024-06-08